Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $374.91 --0%
EPS Growth %: -1.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
SICP, FTCO, OXLC, More
EPS Growth %: -1.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
SICP, FTCO, OXLC, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.09, $0.14 better than the analyst estimate of $0.95. Revenue for the quarter came in at $536.8 million versus the consensus estimate of $537.58 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- Owens Corning (OC) Misses Q3 EPS by 62c, Misses on Revenue
- ArcBest (ARCB) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
